Bosh sahifaVX1 • ETR
add
Vertex Pharmaceuticals Incorporated
Yopilish kursi
447,45 €
Yillik diapazon
315,70 € - 474,80 €
Bozor kapitalizatsiyasi
123,91 mlrd USD
Oʻrtacha hajm
66,00
Narx/foyda
-
Dividend daromadliligi
-
Asosiy maydon
NASDAQ
Yangiliklarda
Investing.com Nigeria
17 soat oldin
Vertex shares retain Buy rating on pain drug data By Investing.com
0,14%
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (USD) | iyn, 2024info | Y/Y qiyosi |
|---|---|---|
Daromad | 2,65 mlrd | 6,11% |
Joriy xarajat | 372,20 mln | 41,74% |
Sof foyda | -3,59 mlrd | -492,44% |
Sof foyda marjasi | -135,83 | -469,81% |
Har bir ulushga tushum | -12,83 | -429,82% |
EBITDA | 988,90 mln | -16,03% |
Amaldagi soliq stavkasi | -5,97% | — |
Balans
Jami aktivlari
Jami passivlari
| (USD) | iyn, 2024info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 5,80 mlrd | -48,42% |
Jami aktivlari | 20,13 mlrd | -1,07% |
Jami passivlari | 5,36 mlrd | 9,81% |
Umumiy kapital | 14,77 mlrd | — |
Tarqatilgan aksiyalar | 258,10 mln | — |
Narxi/balansdagi bahosi | 7,81 | — |
Aktivlardan daromad | 10,61% | — |
Kapitaldan daromad | 13,36% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (USD) | iyn, 2024info | Y/Y qiyosi |
|---|---|---|
Sof foyda | -3,59 mlrd | -492,44% |
Operatsiyalardan naqd pul | -3,75 mlrd | -430,89% |
Sarmoyadan naqd pul | -463,70 mln | -52,58% |
Moliyadan naqd pul | -358,60 mln | -2 172,83% |
Naqd pulning sof oʻzgarishi | -4,58 mlrd | -633,74% |
Boʻsh pul | 629,82 mln | -39,74% |
Haqida
Vertex Pharmaceuticals Incorporated is an American biopharmaceutical company based in Boston, Massachusetts. It was one of the first biotech firms to use an explicit strategy of rational drug design rather than combinatorial chemistry. It maintains headquarters in Boston, Massachusetts, and three research facilities, in San Diego, California, and Milton Park, Oxfordshire, England. Wikipedia
Tashkil etilgan
1989
Sayt
Xodimlar soni
5 400
